DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,097,670 | +2.4% | 40,700 | -1.0% | 0.23% | +6.4% |
| Q2 2023 | $9,864,000 | -8.1% | 41,100 | -3.5% | 0.22% | -19.9% |
| Q1 2023 | $10,736,904 | +95534.7% | 42,600 | +0.7% | 0.27% | -11.7% |
| Q4 2022 | $11,227 | -99.9% | 42,300 | +1.0% | 0.31% | -2.8% |
| Q3 2022 | $10,822,000 | +3.2% | 41,900 | +2.2% | 0.32% | +13.2% |
| Q2 2022 | $10,486,000 | -7.0% | 41,000 | +2.0% | 0.28% | +4.9% |
| Q1 2022 | $11,271,000 | -14.1% | 40,200 | +0.8% | 0.27% | -7.3% |
| Q4 2021 | $13,127,000 | +8.9% | 39,900 | +0.8% | 0.29% | -1.0% |
| Q3 2021 | $12,056,000 | +13.4% | 39,600 | 0.0% | 0.29% | +12.8% |
| Q2 2021 | $10,627,000 | +20.1% | 39,600 | +0.8% | 0.26% | +11.7% |
| Q1 2021 | $8,846,000 | +1.6% | 39,300 | +0.3% | 0.23% | -8.3% |
| Q4 2020 | $8,708,000 | +26.0% | 39,200 | +22.1% | 0.25% | -21.0% |
| Q3 2020 | $6,912,000 | +44.2% | 32,100 | +18.5% | 0.32% | +11.5% |
| Q2 2020 | $4,792,000 | +27.3% | 27,100 | -0.4% | 0.29% | +4.4% |
| Q1 2020 | $3,765,000 | -19.3% | 27,200 | -10.5% | 0.27% | +18.6% |
| Q4 2019 | $4,666,000 | +5.2% | 30,400 | -1.0% | 0.23% | -0.9% |
| Q3 2019 | $4,434,000 | +0.2% | 30,700 | -2.8% | 0.23% | +5.0% |
| Q2 2019 | $4,425,000 | +1.0% | 31,600 | -4.8% | 0.22% | +1.4% |
| Q1 2019 | $4,383,000 | +31.2% | 33,200 | +2.5% | 0.22% | +15.9% |
| Q4 2018 | $3,341,000 | -14.6% | 32,400 | -10.0% | 0.19% | +12.5% |
| Q3 2018 | $3,912,000 | +9.5% | 36,000 | -0.6% | 0.17% | +4.3% |
| Q2 2018 | $3,572,000 | -2.7% | 36,200 | -3.5% | 0.16% | -4.2% |
| Q1 2018 | $3,672,000 | +6.6% | 37,500 | +1.1% | 0.17% | +7.0% |
| Q4 2017 | $3,444,000 | +5.1% | 37,100 | -2.9% | 0.16% | +1.9% |
| Q3 2017 | $3,277,000 | +2.5% | 38,200 | +0.8% | 0.15% | -1.9% |
| Q2 2017 | $3,198,000 | -0.3% | 37,900 | +1.1% | 0.16% | -3.1% |
| Q1 2017 | $3,207,000 | +7.6% | 37,500 | -2.1% | 0.16% | +5.2% |
| Q4 2016 | $2,981,000 | -1.7% | 38,300 | -1.0% | 0.15% | -3.8% |
| Q3 2016 | $3,034,000 | -23.6% | 38,700 | -1.5% | 0.16% | -23.4% |
| Q2 2016 | $3,969,000 | +4.6% | 39,300 | -1.8% | 0.21% | +6.1% |
| Q1 2016 | $3,794,000 | -2.3% | 40,000 | -4.3% | 0.20% | 0.0% |
| Q4 2015 | $3,882,000 | +5.0% | 41,800 | -3.7% | 0.20% | +3.1% |
| Q3 2015 | $3,698,000 | -3.8% | 43,400 | -3.3% | 0.19% | +4.4% |
| Q2 2015 | $3,843,000 | +2.4% | 44,900 | +1.6% | 0.18% | +2.2% |
| Q1 2015 | $3,753,000 | -4.8% | 44,200 | -3.9% | 0.18% | -1.1% |
| Q4 2014 | $3,943,000 | +10.9% | 46,000 | -1.7% | 0.18% | +6.5% |
| Q3 2014 | $3,556,000 | -4.3% | 46,800 | -0.8% | 0.17% | -1.2% |
| Q2 2014 | $3,716,000 | +4.1% | 47,200 | -0.8% | 0.17% | +1.2% |
| Q1 2014 | $3,570,000 | -4.3% | 47,600 | -1.4% | 0.17% | -4.0% |
| Q4 2013 | $3,729,000 | – | 48,300 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |